Fluclotizolam

Tolerance timelines are rules of thumb, not exact schedules, and vary widely between individuals and use patterns.

Fluclotizolam is a thienotriazolodiazepine that was originally synthesized in 1979citation needed but was never developed for medical use or brought to market as a pharmaceutical product. The compound remained obscure for nearly four decades until it resurfaced as a designer drug in the mid-2010s. It was first definitively identified through analytical methods in 2017, joining the growing class of novel benzodiazepines appearing on the research chemical market.

• 
  Step 1 · Automated synthesis

  An autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.

• 
  Step 2 · First-pass review

  A first pass manual review and edit of article prose and copy has been performed by subject-matter expert Lyrea. This does not guarantee factual accuracy. An additional human review for each of this article's citations is yet to be performed.

• Step 3 · Citation reviewPending

  No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.

Spotted a mistake, an outdated claim, or something missing from the Fluclotizolam article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Wish to give generalised feedback? You can do so here.